tirzepatide egfr (Zepbound) showed improved kidney function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Kidney Parameters with Tirzepatide in

McMahon CJ, Hopkins S, Vail A, King AT, Smith D, Illingworth KJ, et al

By combining the power of innovative medications with modern telehealth solutions, individuals can navigate their health challenges more confidently and effectively

High-fat diet determines the composition of the murine gut microbiome independently of obesity (in Eng)

Module 5 is dedicated entirely to practice integration: a monthly membership pricing model with a real 6-month cost pro forma, bundled service structure, membership terms and cancellation policies, documentation and consent templates, compounding pharmacy sourcing guidance, and both organic and digital marketing strategies